Peptide Legal Status in Australia — Regulatory Reference
This page is a plain-language summary of publicly available regulatory information. It is general information only and is not legal advice. Regulations change. Consult the TGA directly or obtain independent legal advice for your circumstances.
Unapproved therapeutic goods and the ARTG
Most peptide products supplied in Australia are unapproved therapeutic goods. That means they are not entered on the Australian Register of Therapeutic Goods (ARTG), the national register of products that have been evaluated by the Therapeutic Goods Administration.
Because these products are not on the ARTG, they have not been assessed by the TGA for safety, quality or effectiveness.
Source: TGA media release — compliance focus on unapproved peptide products
Scheduled peptides
The Poisons Standard lists substances by schedule. Schedule 4 substances are prescription-only medicines, and some Schedule 4 entries also appear in Appendix D, which makes possession without authorisation an offence under state and territory law.
Whether a particular compound is listed can be checked in the current Poisons Standard on the Federal Register of Legislation. Strand does not provide legal advice on individual compounds; buyers are responsible for confirming the status of any compound in their own state or territory before ordering.
Source: Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 — Federal Register of Legislation
Source: Notice of final decisions to amend (or not amend) the current Poisons Standard
The Personal Importation Scheme
The Personal Importation Scheme allows individuals to import goods that are not on the ARTG, under strict conditions.
- The import must be for the person's own use or for an immediate family member, defined as a parent, grandparent, spouse, de facto spouse, child or ward.
- The goods cannot be sold, supplied or given to any other person.
- If the medicine is prescription-only in Australia, a valid Australian prescription or written authority must be held at the time of importation.
- A maximum of a 3-month supply may be imported at one time at the maximum prescribed dose, and no more than a 15-month supply in any 12-month period.
TGA compliance priorities for 2026 and 2027
On 10 June 2026 the TGA formally added unapproved peptide products to its priority compliance focus areas. The TGA is prioritising action against unlawful importation, manufacture, advertising and supply.
Regulatory responses may include infringement notices, product seizures, import interventions, and civil or criminal penalties.
A joint operation with the Australian Border Force and Victoria Police seized peptide products, performance and image enhancing drugs and illicit steroids with an estimated street value in excess of $2 million.
Source: TGA media release — compliance focus on unapproved peptide products
What “research use only” means
A “research use only” label indicates that the supplier is not supplying the product as a therapeutic good. It does not place a product outside the Therapeutic Goods Act.
It does not authorise human or veterinary use, and it does not exempt a supplier from compliance obligations. State and territory legislation also applies to the possession and handling of research chemicals.
Veterinary products are separately regulated
Agricultural and veterinary chemicals are regulated by the Australian Pesticides and Veterinary Medicines Authority (APVMA), not the TGA.
Without APVMA approval, an agvet chemical cannot be legally imported, marketed, supplied or used in Australia.
Source: APVMA — Importing agricultural or veterinary chemicals
How this applies to Strand Peptide Research
All products supplied by Strand Peptide Research are supplied strictly for laboratory research use only. They are not entered on the ARTG and are not approved for human or veterinary use. The TGA's stated position is that products of this kind are unapproved therapeutic goods, and a research-use label does not change that.
Buyers are responsible for compliance with all applicable Commonwealth, state and territory legislation.